Position in AMLX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$4,937,994
-$3,299,896 QoQ
Shares Held
274,944
-53.6% QoQ
Ownership
0.247%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#54
of 205 holders
Holding Since
Sep 2023
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026JUPITER ASSET MANAGEMENT LTD holds $164,709,425 across 6 Drug Manufacturers - Specialty & Generic names. AMLX ranks #5 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELAN |
Elanco Animal Health Inc
|
4,219,279 | $103,836,455 | |
| 2 | ZTS |
Zoetis Inc.
|
429,356 | $30,853,522 | |
| 3 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,642,874 | $16,428,740 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
197,149 | $8,089,022 | |
| 5 | AMLX |
Amylyx Pharmaceuticals, Inc.
This page
|
274,944 | $4,937,994 | |
| 6 | VTRS |
Viatris Inc
|
35,497 | $563,692 |
All Filings in AMLX
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,937,994 | 274,944 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $8,237,890 | 592,654 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $188,133 | 15,574 | Shares | Sole | 2026-02-10 | |
| 2023-12-31 | $15,616,447 | 1,060,900 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $11,896,666 | 649,736 | Shares | Defined | 2023-11-09 | |
| No filing history on record for this holder in this stock. | ||||||